We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$949M
AUM Growth
+$10.7M
Cap. Flow
-$13.1M
Cap. Flow %
-1.38%
Top 10 Hldgs %
22.38%
Holding
286
New
5
Increased
81
Reduced
149
Closed
5

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.25%
2 Healthcare 14.37%
3 Financials 12.31%
4 Consumer Staples 12.04%
5 Technology 11.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STT icon
126
State Street
STT
$53.1B
$2.09M 0.22%
23,304
+382
+2% +$31.8K
VSS icon
127
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12.1B
$2.09M 0.22%
19,298
-275
-1% -$29.3K
TGT icon
128
Target
TGT
$74.1B
$2.08M 0.22%
39,836
-9,271
-19% -$507K
AMAT icon
129
Applied Materials
AMAT
$366B
$2.04M 0.22%
49,447
-795
-2% -$33.8K
AFL icon
130
Aflac
AFL
$58.4B
$2M 0.21%
51,484
+556
+1% +$20.9K
INTU icon
131
Intuit
INTU
$97.9B
$1.96M 0.21%
14,778
+17
+0.1% +$2.21K
LDOS icon
132
Leidos
LDOS
$17.7B
$1.95M 0.21%
37,759
+62
+0.2% +$3.3K
VHT icon
133
Vanguard Health Care ETF
VHT
$19.3B
$1.94M 0.2%
13,178
+905
+7% +$128K
XES icon
134
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$385M
$1.87M 0.2%
12,107
-1,312
-10% -$226K
TMO icon
135
Thermo Fisher Scientific
TMO
$230B
$1.86M 0.2%
10,675
+301
+3% +$50.6K
BIIB icon
136
Biogen
BIIB
$32.3B
$1.85M 0.2%
6,835
-67
-1% -$17.7K
EVH icon
137
Evolent Health
EVH
$520M
$1.81M 0.19%
71,350
-45,000
-39% -$1.08M
VTI icon
138
Vanguard Morningstar Total Stock Market ETF
VTI
$687B
$1.77M 0.19%
14,205
-30
-0.2% -$3.7K
OXY icon
139
Occidental Petroleum
OXY
$59.1B
$1.76M 0.19%
29,461
-6,048
-17% -$370K
DXCM icon
140
DexCom
DXCM
$34.3B
$1.72M 0.18%
94,080
+19,236
+26% +$355K
VCR icon
141
Vanguard Consumer Discretionary ETF
VCR
$6.04B
$1.7M 0.18%
11,971
+525
+5% +$74.1K
SCZ icon
142
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.3B
$1.69M 0.18%
29,168
-1,442
-5% -$82.2K
SYK icon
143
Stryker
SYK
$127B
$1.66M 0.17%
11,938
+160
+1% +$22K
ESRX
144
DELISTED
Express Scripts Holding Company
ESRX
$1.65M 0.17%
25,894
-4,893
-16% -$307K
TJX icon
145
TJX Companies
TJX
$149B
$1.63M 0.17%
45,240
+3,610
+9% +$136K
TFCFA
146
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$1.62M 0.17%
57,223
-4,380
-7% -$126K
IWM icon
147
iShares Russell 2000 ETF
IWM
$80.8B
$1.6M 0.17%
11,382
IYZ icon
148
iShares US Telecommunications ETF
IYZ
$1.28B
$1.55M 0.16%
48,049
-1,415
-3% -$46.8K
BDX icon
149
Becton Dickinson
BDX
$51.6B
$1.54M 0.16%
8,088
+169
+2% +$30.9K
SAIC icon
150
Saic
SAIC
$5.33B
$1.53M 0.16%
22,076
+35
+0.2% +$2.57K

Similar funds

Dowling & Yahnke's Q2 2017 Portfolio in Review

As of Q2 2017, Dowling & Yahnke held 286 positions worth $949M, up 1.1% from $939M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 3.5%. Dowling & Yahnke opened 5 new positions and exited 5, leaving the 286-position portfolio largely intact.

By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Dowling & Yahnke's largest Q2 2017 buy was Altaba Inc: 44,542 shares worth $2.43M.
  • Dowling & Yahnke added most to DexCom in Q2 2017, an estimated $355K increase.
  • Dowling & Yahnke's biggest Q2 2017 reduction was Reliance Steel & Aluminium, cutting an estimated $1.96M.
  • Dowling & Yahnke fully exited Yahoo Inc in Q2 2017, selling an estimated $1.99M.
  • Dowling & Yahnke's ten largest holdings make up 22% of its $949M portfolio in Q2 2017.
  • Dowling & Yahnke opened 5 new positions and closed 5 in Q2 2017.
  • Dowling & Yahnke's portfolio value rose 1.1% quarter-over-quarter to $949M.

Based on Dowling & Yahnke's 13F filing for Q2 2017, filed 3 Aug 2017.